India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
State Ba 260.85 0.11
Reliance 1101.65 4.11
Tata Stl 553.60 0.19
Tata Mot 174.80 2.46
Cipla Lt 633.85 0.98
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 1ISIN Demat: INE044A01036
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
21-Sep-2018       Sun Pharma announces Australian TGA approval of ILUMYA IRIS
18-Sep-2018       Sun Pharma gets European Commission nod for ILUMETRI IRIS
14-Sep-2018       Sun Pharma Industries receives USFDA approval for XELPROS IRIS
11-Sep-2018       Sun Pharma to acquire 18.75% stake in Israeli Co-Tarsius IRIS
16-Aug-2018       Sun Pharma gets USFDA approval for Cequa ophthalmic solution IRIS
07-Aug-2018       Sun Pharma launches Novel Drug Kapspargo Sprinkle in USA IRIS
25-Jul-2018       Sun Pharma launches of generic glumetza tablets in US IRIS
18-Jul-2018       Sun Pharma gets USFDA approval of INFUGEM injection IRIS
12-Jul-2018       Sun Pharma arm Dusa files lawsuit against Biofrontera IRIS
12-Jun-2018       Sun Pharma receives USFDA EIR for Halol facility IRIS
25-May-2018       Sun Pharmaceutical Industries quarterly earnings up 7%  IRIS
23-May-2018       Sun Pharma announces USFDA approval of YONSA IRIS
18-May-2018       Sun Pharma launches generic Welchol tablets in US IRIS
22-Mar-2018       Sun Pharma announces USFDA approval of ILUMYA drug IRIS
17-Jan-2018       Sun Pharma settles patent dispute for generic Linzess IRIS
27-Dec-2017       Sun Pharma announces USFDA acceptance of NDA for OTX-101 IRIS
26-Oct-2017       Sun Pharma gets USFDA approval for generic Coreg capsules IRIS
13-Oct-2017       Sun Pharma to hike stake in Ranbaxy Malaysia to 79.5% IRIS
12-Oct-2017       Sun Pharma receives EIR from USFDA for Dadra facility IRIS
20-Sep-2017       Sun Pharma's arm receives USFDA approval for new label for Odomzo IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited